Search

Author/Creator Symanowski, James T

1. Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials. Issue 9 (September 2017)

Authors:
Bhutani, Manisha; Zhang, Qing; Friend, Reed; Voorhees, Peter M; Druhan, Lawrence J; Barlogie, Bart; Sonneveld, Pieter; Morgan, Gareth J; Symanowski, James T; Avalos, Belinda R; Copelan, Edward A; Usmani, Saad Z
Journal:
Lancet
Issue:
Volume 4:Issue 9(2017)
Page Start:
e443
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research. (December 2016)

Authors:
Penson, David F; Lin, Daniel W; Karsh, Lawrence; Quinn, David I; Shevrin, Daniel H; Shore, Neal; Symanowski, James T; Brown, Bruce; Forer, David; Wong, Elaine K; Flanders, Scott C
Journal:
Future oncology
Issue:
Volume 12:Number 23(2016)
Page Start:
2689
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET. (8th February 2018)

Authors:
Flanders, Scott C; Kim, Janet; Wilson, Samuel; Braziunas, Jeffrey; Greenfield, Sheldon; Billimek, John; Lechpammer, Stanislav; Lin, Daniel W; Karsh, Lawrence; Quinn, David I; Shevrin, Daniel; Shore, Neal D; Symanowski, James T; Penson, David F
Journal:
Future oncology
Issue:
Volume 14:Number 6(2018)
Page Start:
527
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search